SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-027640
Filing Date
2020-10-06
Accepted
2020-10-06 18:00:36
Documents
2
Period of Report
2020-10-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1565
2 EX-24 DOCUMENT attachment1.htm EX-24 3148
  Complete submission text file 0000899243-20-027640.txt   6161
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Issuer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INOVIO PHARMACEUTICALS, INC. 660 W. GERMANTOWN PIKE, SUITE 110 PLYMOUTH MEETING PA 19462
Business Address
Miller Ann Calby (Reporting) CIK: 0001771423 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38268 | Film No.: 201227709